Genome-wide RNA interference screen identifies previously undescribed regulators of polyglutamine aggregation
Open accessThe DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.
Abstract
Protein misfolding and the formation of aggregates are increasingly recognized components of the pathology of human genetic disease and hallmarks of many neurodegenerative disorders. As exemplified by polyglutamine diseases, the propensity for protein misfolding is associated with the length of polyglutamine expansions and age-dependent changes in protein-folding homeostasis, suggesting a critical role for a protein homeostatic buffer. To identify the complement of protein factors that protects cells against the formation of protein aggregates, we tested transgenic Caenorhabditis elegans strains expressing polyglutamine expansion yellow fluorescent protein fusion proteins at the threshold length associated with the age-dependent appearance of protein aggregation. We used genome-wide RNA interference to identify genes that, when suppressed, resulted in the premature appearance of protein aggregates. Our screen identified 186 genes corresponding to five principal classes of polyglutamine regulators: genes involved in RNA metabolism, protein synthesis, protein folding, and protein degradation; and those involved in protein trafficking. We propose that each of these classes represents a molecular machine collectively comprising the protein homeostatic buffer that responds to the expression of damaged proteins to prevent their misfolding and aggregation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Impaired intracellular transport, a hallmark of HD, is closely linked to PC dysfunction, which can alter ciliary structure and disrupt the trafficking of signaling molecules regulating Shh and Wnt pathways [54,171,172].”
From The Impact of Neurotoxin Proteins Trafficked by Primary Cilia and Extracellular Vesicles in Neurodegenerative Diseases (2025) · cites this paper as [171]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Impaired intracellular transport, a hallmark of HD, is closely linked to PC dysfunction, which can alter ciliary structure and disrupt the trafficking of signaling molecules regulating Shh and Wnt pathways [54,171,172].”
From The Impact of Neurotoxin Proteins Trafficked by Primary Cilia and Extracellular Vesicles in Neurodegenerative Diseases (2025) · cites this paper as [171]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
TRiC/CCT cooperates with different upstream chaperones in the folding of distinct protein classes
Siegers, K., Bölter, B., Schwarz, J. P., Böttcher, U. M. K., Guha, S., & Hartl, F. U. (2003) · The EMBO Journal · doi:10.1093/emboj/cdg483 · Cited by 118
RetractedSystematic functional analysis of the Caenorhabditis elegans genome using RNAi
Kamath, R. S., Fraser, A. G., Dong, Y., Poulin, G., Durbin, R., Gotta, M., Kanapin, A., Le Bot, N., Moreno, S., Sohrmann, M., et al. (2003) · Nature · doi:10.1038/nature01278 · Cited by 3,616
Spillantini, M. G., Crowther, R. A., Jakes, R., Hasegawa, M., & Goedert, M. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.11.6469 · Cited by 2,868
Aggregation of Huntingtin in Neuronal Intranuclear Inclusions and Dystrophic Neurites in Brain
DiFiglia, M., Sapp, E., Chase, K. O., Davies, S. W., Bates, G. P., Vonsattel, J. P., & Aronin, N. (1997) · Science · doi:10.1126/science.277.5334.1990 · Cited by 2,439
Quality control in the endoplasmic reticulum
Ellgaard, L., & Helenius, A. (2003) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1052 · Cited by 2,126
Timmons, L., Court, D. L., & Fire, A. (2001) · Gene · doi:10.1016/s0378-1119(00)00579-5 · Cited by 1,843
Regulation of aging and age-related disease by DAF-16 and heat-shock factor
Hsu, A.-L., Murphy, C. T., & Kenyon, C. (2003) · Science · doi:10.1126/science.1083701 · Cited by 1,513
Unfolding the role of protein misfolding in neurodegenerative diseases
Soto, C. (2003) · Nature Reviews Neuroscience · doi:10.1038/nrn1007 · Cited by 1,506
Scherzinger, E., Lurz, R., Turmaine, M., Mangiarini, L., Hollenbach, B., Hasenbank, R., Bates, G. P., Davies, S. W., Lehrach, H., & Wanker, E. E. (1997) · Cell · doi:10.1016/s0092-8674(00)80514-0 · Cited by 1,291
Toxic Proteins in Neurodegenerative Disease
Taylor, J. P., Hardy, J., & Fischbeck, K. H. (2002) · Science · doi:10.1126/science.1067122 · Cited by 1,251
Cited by
Items 101–200 of 423
Link, C. D., Fonte, V. G., Hiester, B. G., Yerg, J., Ferguson, J., Csontos, S., Silverman, M. A., & Stein, G. H. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m505581200 · Cited by 85
de Pril, R., Fischer, D. F., Roos, R. A. C., & van Leeuwen, F. W. (2006) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2006.09.006 · Cited by 89
Heat shock factor 1 ameliorates proteotoxicity in cooperation with the transcription factor NFAT
Hayashida, N., Fujimoto, M., Tan, K., Prakasam, R., Shinkawa, T., Li, L., Ichikawa, H., Takii, R., & Nakai, A. (2010) · The EMBO Journal · doi:10.1038/emboj.2010.225 · Cited by 89
“…(SDR family) member 2 (DHRS2), and PDZ domain-containing 3 (PDZK3) encoding a scaffold protein, and were different from the genes that had a suppressive effect on polyQ aggregation in C. elegans and Drosophila, except for aB-crystalline (Nollen et al, 2004; Bilen and Bonini, 2007).”
Shinkawa, T., Tan, K., Fujimoto, M., Hayashida, N., Yamamoto, K., Takaki, E., Takii, R., Prakasam, R., Inouye, S., Mezger, V., et al. (2011) · Molecular Biology of the Cell · doi:10.1091/mbc.e11-04-0330 · Cited by 94
“There is increasing evidence that non-HSP proteins, including components of an ubiquitin proteasome pathway, regulate proteostasis capacity (Nollen et al., 2004; Bilen and Bonini, 2007).”
Neurodegenerative diseases: Lessons from genome‐wide screens in small model organisms
van Ham, T. J., Breitling, R., Swertz, M. A., & Nollen, E. A. A. (2009) · EMBO Molecular Medicine · doi:10.1002/emmm.200900051 · Cited by 98
Self-citationZourlidou, A., Gidalevitz, T., Kristiansen, M., Landles, C., Woodman, B., Wells, D. J., Latchman, D. S., de Belleroche, J., Tabrizi, S. J., Morimoto, R. I., et al. (2007) · Human Molecular Genetics · doi:10.1093/hmg/ddm057 · Cited by 81
Self-citationvan Ham, T. J., Esposito, A., Kumita, J. R., Hsu, S. D., Schierle, G. S. K., Kaminski, C. F., Dobson, C. M., Nollen, E. A. A., & Bertoncini, C. W. (2009) · Journal of Molecular Biology · doi:10.1016/j.jmb.2009.10.066 · Cited by 87
Self-citationThakker, D. R., Hoyer, D., & Cryan, J. F. (2005) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2005.08.006 · Cited by 80
Kubota, S., KUBOTA, H. Y., & Nagata, K. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0600195103 · Cited by 78
Teschendorf, D., & Link, C. D. (2009) · Molecular Neurodegeneration · doi:10.1186/1750-1326-4-38 · Cited by 75
“Indeed, a large scale RNAi screen for modifiers of YFP::polyQ aggregation identified a large set of genes involved in protein folding or degradation that increased polyQ aggregation when their expression was knocked down [17].”
Vang, S., Corydon, T. J., Børglum, A. D., Scott, M. D., Frydman, J., Mogensen, J., Gregersen, N., & Bross, P. (2005) · FEBS Journal · doi:10.1111/j.1742-4658.2005.04630.x · Cited by 76
Choe, K. P., & Strange, K. B. (2008) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00450.2008 · Cited by 82
“Protein aggregates or aggregation intermediates may be sorted through endosomes and degraded in lysosomes or ubiquitinylated and degraded by the 26S proteasome, two well-known pathways that inhibit protein aggregation (17, 43, 52).”
InfluentialHSF1 Protects Neurons through a Novel Trimerization- and HSP-Independent Mechanism
Verma, P., Pfister, J. A., Mallick, S., & D’Mello, S. R. (2014) · Journal of Neuroscience · doi:10.1523/jneurosci.3039-13.2014 · Cited by 76
“Indeed, knock-down of HSF1 expression enhances the neuropathological effects of toxic misfolded proteins (Nollen et al., 2004; Kraemer et al., 2006; Wang et al., 2009), whereas overexpression protects in models of diverse proteinopathic disorders (Fujimoto et al., 2005; Hayashida et al., 2010;…”
InfluentialGenetic screens in Caenorhabditis elegans models for neurodegenerative diseases
Sin, O., Michels, H., & Nollen, E. A. A. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2014.01.015 · Cited by 80
Self-citationPerni, M., Challa, P. K., Kirkegaard, J. B., Limbocker, R., Koopman, M., Hardenberg, M. C., Sormanni, P., Müller, T., Saar, K. L., Roode, L. W. Y., et al. (2018) · Journal of Neuroscience Methods · doi:10.1016/j.jneumeth.2018.02.005 · Cited by 76
Self-citationRNA interference: from model organisms towards therapy for neural and neuromuscular disorders
Buckingham, S. D., Esmaeili, B., Wood, M., & Sattelle, D. B. (2004) · Human Molecular Genetics · doi:10.1093/hmg/ddh224 · Cited by 76
Organismal Protein Homeostasis Mechanisms
Hoppe, T., & Cohen, E. (2020) · Genetics · doi:10.1534/genetics.120.301283 · Cited by 72
Downregulation of the Hsp90 System Causes Defects in Muscle Cells of Caenorhabditis Elegans
Gaiser, A. M., Kaiser, C. J. O., Haslbeck, V., & Richter, K. (2011) · PLoS ONE · doi:10.1371/journal.pone.0025485 · Cited by 77
“coli to the nematodes according to standard procedures [61,62].”
Genome-wide RNAi screens in Caenorhabditis elegans: impact on cancer research
Poulin, G. B., Nandakumar, R., & Ahringer, J. (2004) · Oncogene · doi:10.1038/sj.onc.1208010 · Cited by 68
“RNAi by feeding is versatile and can be performed in liquid culture in 96-well format, reducing the screening labour (Nollen et al., 2004).”
Nussbaum-Krammer, C. I., & Morimoto, R. I. (2014) · Disease Models & Mechanisms · doi:10.1242/dmm.013011 · Cited by 77
“decipher pathways of known disease genes (Nollen et al., 2004; van Ham et al., 2008; Silva et al., 2011; Treusch et al., 2011; Lejeune et al., 2012; Lim et al., 2012).”
Self-citationMolecular mechanisms of amyloid formation in living systems
Sinnige, T. (2022) · Chemical Science · doi:10.1039/d2sc01278b · Cited by 67
Boasquívis, P. F., Silva, G. M. M., Paiva, F. A., Cavalcanti, R. M., Núñez, C. V., & Oliveira, R. D. P. (2018) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2018/9241308 · Cited by 76
Protein stress and stress proteins: implications in aging and disease
Sőti, C., & Csermely, P. (2007) · Journal of Biosciences · doi:10.1007/s12038-007-0050-z · Cited by 76
“Polyglutamine protein (polyQ) aggregation increases with age, and downregulation of chaperones and protein degradation machinery in C. elegans accelerates the onset of aggregation, showing an age-dependent impairment of the protein homeostasis buffer (Hsu et al 2003, Nollen et al 2004).”
Sinnige, T., Yu, A., & Morimoto, R. I. (2020) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-40204-4_4 · Cited by 65
Self-citationLejeune, F., Mesrob, L., Parmentier, F., Bicep, C., Vázquez‐Manrique, R. P., Parker, J. A., Vert, J., Tourette, C., & Néri, C. (2012) · BMC Genomics · doi:10.1186/1471-2164-13-91 · Cited by 67
“elegans [40,41], Consistent with the notion that aggregation and cytotoxicity can be genetically uncoupled [41], the overlap with our RNAi screen was small with 12 modifiers of 128Q-neuron dysfunction previously found to enhance the aggregation of 35Q-peptides when knocked-down by RNAi [40] and three other modifiers o…”
Stress and aging induce distinct polyQ protein aggregation states
Mazzeo, L. E. M., Dersh, D., Boccitto, M., Kalb, R. G., & Lamitina, T. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1108766109 · Cited by 71
“To determine whether the osmotically induced foci were in fact aggregates, we analyzed their biophysical properties using the fluorescence recovery after photobleaching (FRAP) technique (11, 12, 30, 31) (Fig.”
Saegusa, K., Sato, M., Sato, K., Nakajima‐Shimada, J., Harada, A., & Sato, K. (2014) · Molecular Biology of the Cell · doi:10.1091/mbc.e13-09-0530 · Cited by 61
“CCT is also known to prevent aggregation of polyglutamine (polyQ) proteins, which cause cytotoxicity and lead to neurodegenerative disorders, including Huntington’s disease (Nollen et al., 2004; Kitamura et al., 2006).”
Xiao, L., Li, H., Zhang, J., Yang, F., Huang, A., Deng, J., Liang, M., Ma, F., Hu, M., & Huang, Z. (2014) · Molecules · doi:10.3390/molecules19067757 · Cited by 62
“elegans strain AM141 expresses polyQ40::YFP fusion proteins in body wall muscle cells and shows a discrete fluorescent aggregate phenotype when reaching adulthood [30].”
Kirstein, J., Arnsburg, K., Scior, A., Szlachcic, A., Guilbride, D. L., Morimoto, R. I., Bukau, B., & Nillegoda, N. B. (2017) · Aging Cell · doi:10.1111/acel.12686 · Cited by 53
“Taken together, these findings agree with the direct role reported for constitutive HSP-1, but not induced HSP-70 forms, in aging and age-dependent pathophysiological conditions associated with protein aggregation in nematodes (Nollen et al., 2004; Brehme et al., 2014).”
Self-citationProteostasis of Huntingtin in Health and Disease
Koyuncu, S., Fatima, A., Gutiérrez-García, R., & Vílchez, D. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18071568 · Cited by 67
“Indeed, overexpression of members of the HSP90 family does not suppress polyQ toxicity [51].”
InfluentialWalker, A. C., Bhargava, R., Vaziriyan-Sani, A. S., Pourciau, C., Donahue, E. T., Dove, A. S., Gebhardt, M. J., Ellward, G. L., Romeo, T., & Czyż, D. M. (2021) · PLoS Pathogens · doi:10.1371/journal.ppat.1009510 · Cited by 62
Keith, S. A., Maddux, S., Zhong, Y., Chinchankar, M. N., Ferguson, A. A., Ghazi, A., & Fisher, A. L. (2016) · PLoS Genetics · doi:10.1371/journal.pgen.1005823 · Cited by 64
“Particularly, the inhibition of several proteasome subunits via RNAi is known to increase the aggregation of this protein [41].”
A quantitative genome-wide RNAi screen in C. elegans for antifungal innate immunity genes
Zugasti, O., Thakur, N., Belougne, J., Squiban, B., Kurz, C. L., Soulé, J., Omi, S., Tichit, L., Pujol, N., & Ewbank, J. J. (2016) · BMC Biology · doi:10.1186/s12915-016-0256-3 · Cited by 65
“Suppressors of polyglutamine aggregation [77] 19 173 9.”
The Stress of Misfolded Proteins
Brignull, H. R., Morley, J. F., & Morimoto, R. I. (2007) · Springer eBooks · doi:10.1007/978-0-387-39975-1_15 · Cited by 63
“Of the 72 candidate gene modifiers analyzed only four showed an earlier appearance of foci in Q33 and Q35 animals revealing an unexpected specificity among known modifiers of protein folding.(83) These effects were dependent on the presence of an expanded polyQ motif as no foci were observed for any of the 72 RNAi bac…”
Self-citationWest, J. D., Wang, Y., & Morano, K. A. (2012) · Chemical Research in Toxicology · doi:10.1021/tx300264x · Cited by 64
Tu, Z., Argmann, C., Wong, K. K., Mitnaul, L. J., Edwards, S., Sach, I. C., Zhu, J., & Schadt, E. E. (2009) · Genome Research · doi:10.1101/gr.087890.108 · Cited by 59
Protective Role of DNJ-27/ERdj5 in Caenorhabditis elegans Models of Human Neurodegenerative Diseases
Muñoz-Lobato, F., Rodríguez-Palero, M. J., Naranjo-Galindo, F. J., Shephard, F., Gaffney, C. J., Szewczyk, N. J., Hamamichi, S., Caldwell, K. A., Caldwell, G. A., Link, C. D., et al. (2014) · Antioxidants & Redox Signaling · doi:10.1089/ars.2012.5051 · Cited by 57
“The expression of either GFP or YFP fused to different numbers of glutamine residues in C. elegans body wall muscle cells leads to polyQ-dependent aggregation and toxicity when the number of glutamine expansions is greater than 35–40 residues (47, 49).”
InfluentialDouglas, P. M., Summers, D. W., & Cyr, D. (2009) · Prion · doi:10.4161/pri.3.2.8587 · Cited by 66
Noormohammadi, A., Calculli, G., Gutiérrez-García, R., Khodakarami, A., Koyuncu, S., & Vílchez, D. (2017) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-017-2602-1 · Cited by 62
Parasite neuropeptide biology: Seeding rational drug target selection?
McVeigh, P., Atkinson, L. E., Marks, N. J., Mousley, A., Dalzell, J. J., Sluder, A. E., Hammerland, L. G., & Maule, A. G. (2011) · International Journal for Parasitology Drugs and Drug Resistance · doi:10.1016/j.ijpddr.2011.10.004 · Cited by 61
Noh, J.-Y., Lee, H., Song, S., Kim, N. S., Im, W., Kim, M., Seo, H., Chung, C.-W., Chang, J.-W., Ferrante, R. J., et al. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m807620200 · Cited by 57
Lee, A. L., Ung, H. M., Sands, L. P., & Kikis, E. A. (2017) · PLoS ONE · doi:10.1371/journal.pone.0173644 · Cited by 61
Polyglutamine gene function and dysfunction in the ageing brain
Hands, S. L., Sinadinos, C., & Wyttenbach, A. (2008) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2008.05.008 · Cited by 63
Irfan, Z., Khanam, S., Karmakar, V., Firdous, S. M., Khier, B. S. I. A. E., Khan, I., Rehman, M. U., & Khan, A. (2022) · Brain Sciences · doi:10.3390/brainsci12101389 · Cited by 58
“interrupt transcription and the UPS (Figure 4) [103].”
Model systems of protein-misfolding diseases reveal chaperone modifiers of proteotoxicity
Brehme, M., & Voisine, C. (2016) · Disease Models & Mechanisms · doi:10.1242/dmm.024703 · Cited by 56
“2014; Fonte et al., 2008), through knockdown (Fonte et al., 2002; Nollen et al., 2004; Kraemer et al., 2006; Kaltenbach et al., 2007; Hamamichi et al., 2008; Kuwahara et al., 2008; Van Ham et al., 2008; Roodveldt et al., 2009; Wang et al., 2009; Zhang et al., 2010; Calamini et al., 2011; Silva et…”
Koopman, M., Peter, Q. A. E., Seinstra, R. I., Perni, M., Vendruscolo, M., Dobson, C. M., Knowles, T. P. J., & Nollen, E. A. A. (2020) · Nature Protocols · doi:10.1038/s41596-020-0321-9 · Cited by 54
Self-citationKirstein‐Miles, J., & Morimoto, R. I. (2010) · Developmental Dynamics · doi:10.1002/dvdy.22292 · Cited by 48
“a SPECIAL ISSUE REVIEWS-A PEER REVIEWED FORUM Caenorhabditis Elegans as a Model System to Study Intercompartmental Proteostasis:”
Self-citationGaiser, A. M., Brandt, F., & Richter, K. (2009) · Journal of Molecular Biology · doi:10.1016/j.jmb.2009.06.051 · Cited by 55
Cornaglia, M., Krishnamani, G. H., Mouchiroud, L., Sorrentino, V., Lehnert, T., Auwerx, J. H., & Gijs, M. A. M. (2016) · Molecular Neurodegeneration · doi:10.1186/s13024-016-0083-6 · Cited by 56
“elegans models expressing protein aggregation in muscle cells are useful for screening neurodegenerative phenotypes about Parkinson’s and Huntington’s diseases [32–34].”
Genome-wide high-throughput screens in functional genomics
Friedman, A. A., & Perrimon, N. (2004) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2004.07.010 · Cited by 51
Kim, H., Calatayud, C., Guha, S. K., Fernández‐Carasa, I., Berkowitz, L. A., Carballo‐Carbajal, I., Ezquerra, M., Fernández‐Santiago, R., Kapahi, P., Raya, Á., et al. (2018) · Molecular Neurobiology · doi:10.1007/s12035-018-0881-7 · Cited by 52
“Aggregate Quantification The quantification of aggregates was performed as previously described [83].”
Kalathur, R. K. R., Hernández‐Prieto, M. A., & Futschik, M. E. (2012) · BMC Neurology · doi:10.1186/1471-2377-12-47 · Cited by 47
“To explain the influence of RNA splicing genes on aggregation, it has been proposed that the disruption of RNA splicing interferes with protein homeostasis and enhances aggregation by a general increase of misfolded proteins [13].”
Kim, W., Hendricks, G. L., Lee, K., & Mylonakis, E. E. (2017) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2017.1319358 · Cited by 48
Sin, O., & Nollen, E. A. A. (2015) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-015-1985-0 · Cited by 47
Self-citationO’Reilly, L. P., Long, O. S., Çobanoğlu, M. C., Benson, J. A., Luke, C. J., Miedel, M. T., Hale, P. D., Perlmutter, D. H., Bahar, İ., Silverman, G. A., et al. (2014) · Human Molecular Genetics · doi:10.1093/hmg/ddu236 · Cited by 45
“Huntington’s disease) (23), a-synuclein mutants (e.”
Genetic modifiers of neurological disease
Kearney, J. A. (2011) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2010.12.007 · Cited by 50
“elegans have been used for genome-wide screens to identify modifiers of α-synuclein inclusion formation, tau-induced pathology, polyglutamine aggregation, and mutant SOD1 aggregation [38–41].”
Large-Scale Screen for Modifiers of Ataxin-3-Derived Polyglutamine-Induced Toxicity in Drosophila
Voßfeldt, H., Butzlaff, M., Prüßing, K., Chárthaigh, R.-A. N., Karsten, P., Lankes, A., Hamm, S., Simons, M., Adryan, B., Schulz, J. B., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0047452 · Cited by 46
“To our surprise, the overlap of the two aggregation screens [34,35] was as high as with our screen (Figure 4).”
Khabirova, E., Moloney, A. M., Marciniak, S. J., Williams, J. H., Lomas, D. A., Oliver, S. G., Favrin, G., Sattelle, D. B., & Crowther, D. C. (2014) · PLoS ONE · doi:10.1371/journal.pone.0102985 · Cited by 44
“CCT8 and MOB4 have not been observed as modifiers in any other worm models of neurodegeneration however TCP1 and ACTB RNAi also modify polyQ toxicity [22,23,24].”
Lee, J., Yerbury, J. J., Farrawell, N. E., Shearer, R. F., Constantinescu, P., Hatters, D. M., Schroder, W. A., Suhrbier, A., Wilson, M. R., Saunders, D. N., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0130136 · Cited by 47
“elegans identified RNA synthesis, protein synthesis, protein folding, protein transport and protein degradation as vital classes of genes that control polyQ protein aggregation [45].”
Caenorhabditis elegans as a Model System for Parkinson’s Disease
Schmidt, E., Seifert, M., & Baumeister, R. (2007) · Neurodegenerative Diseases · doi:10.1159/000101845 · Cited by 44
Burkewitz, K., Choe, K. P., Lee, E. C., Deonarine, A., & Strange, K. B. (2012) · PLoS ONE · doi:10.1371/journal.pone.0034153 · Cited by 47
“elegans, silencing of genes required for protein synthesis, including genes encoding translation initiation factors, induces early onset of spontaneous polyglutamine-YFP aggregation [57].”
Rudich, P. D., Snoznik, C., Watkins, S. C., Monaghan, J., Pandey, U. B., & Lamitina, S. T. (2017) · Human Molecular Genetics · doi:10.1093/hmg/ddx372 · Cited by 41
Functional Subunits of Eukaryotic Chaperonin CCT/TRiC in Protein Folding
Kabir, M. A., Uddin, W., Narayanan, A., Reddy, P. K., Jairajpuri, M. A., Sherman, F., & Ahmad, Z. (2011) · Journal of Amino Acids · doi:10.4061/2011/843206 · Cited by 41
“elgans has identified six out of eight subunits of CCT as suppressors of polyQ aggregation, suggesting that CCT can bind polyQ and inhibit the formation of toxic aggregates [200].”
The AXH Domain Adopts Alternative Folds
de Chiara, C., Menon, R. P., Adinolfi, S., de Boer, J., Ktistaki, E., Kelly, G. P., Calder, L. J., Kioussis, D., & Pastore, A. (2005) · Structure · doi:10.1016/j.str.2005.02.016 · Cited by 45
Hao, Y., Montiel, R., Abubucker, S., Mitreva, M., & Simões, N. (2009) · Molecular and Biochemical Parasitology · doi:10.1016/j.molbiopara.2009.10.002 · Cited by 41
Therapeutic Approaches for Inhibition of Protein Aggregation in Huntington’s Disease
Kim, S., & Kim, K. (2014) · Experimental Neurobiology · doi:10.5607/en.2014.23.1.36 · Cited by 44
“elegans, the eukaryotic chaperonin TCP-1 Ring Complex [TRiC, also called to chaperonin containing TCP-1 (CCT)], a member of HSP60 family, have been suggested to have a significant role in protecting against polyQ aggregation [55].”
Self-citationFisher, M. T. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0606106103 · Cited by 40
Connecting the dots in Huntington's disease with protein interaction networks.
Giorgini, F., & Muchowski, P. J. (2005) · Genome biology · doi:10.1186/gb-2005-6-3-210 · Cited by 45
“One method would be to validate the candidates using models of polyQ disease in organisms such as fruit flies, yeast, and the nematode Caenorhabditis elegans, which have already yielded many genetic modifiers of polyQ toxicity [25-29].”
Laing, R., Doyle, S. R., McIntyre, J., Maitland, K., Morrison, A. A., Bartley, D. J., Kaplan, R. M., Chaudhry, U. N., Sargison, N. D., Tait, A., et al. (2022) · PLoS Pathogens · doi:10.1371/journal.ppat.1010545 · Cited by 43
Protein homeostasis and molecular chaperones in aging
Arslan, M. A., Csermely, P., & Sőti, C. (2006) · Biogerontology · doi:10.1007/s10522-006-9053-7 · Cited by 45
“PolyQ aggregation increases with age, and downregulation of chaperones and protein degradation machinery in C. elegans accelerates the onset of aggregation, showing an age-dependent impairment of the protein homeostasis buffer (Hsu et al. 2003; Nollen et al. 2004).”
Ubiquitin conjugating enzymes participate in polyglutamine protein aggregation
Howard, R. A., Sharma, P., Hajjar, C., Caldwell, K. A., Caldwell, G. A., du Breuil, R., Moore, R., & Boyd, L. (2007) · BMC Cell Biology · doi:10.1186/1471-2121-8-32 · Cited by 37
“A similar strain was used to screen for genes that affect the timing of aggregate accumulation [26].”
The pivotal role of ubiquitin-activating enzyme E1 (UBA1) in neuronal health and neurodegeneration
Lambert-Smith, I. A., Saunders, D. N., & Yerbury, J. J. (2020) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2020.105746 · Cited by 39
Strange, K. B. (2007) · Journal of Experimental Biology · doi:10.1242/jeb.000125 · Cited by 37
Modifiers of solid RNP granules control normal RNP dynamics and mRNA activity in early development
Hubstenberger, A., Cameron, C., Noble, S. L., Keenan, S., & Evans, T. C. (2015) · The Journal of Cell Biology · doi:10.1083/jcb.201504044 · Cited by 36
“In support of this, the CCT complex promotes RNP coassembly in oocytes but suppresses Q35 aggregation in somatic cells and PB formation in yeast (Nollen et al., 2004; Nadler-Holly et al., 2012).”
Lentiviral Vector-Mediated Gene Transfer and RNA Silencing Technology in Neuronal Dysfunctions
Dreyer, J. (2010) · Molecular Biotechnology · doi:10.1007/s12033-010-9334-x · Cited by 41
“Unaffected individuals have between 11 and 35 poly(Q) repeats as opposed to 38 and 62 repeats in patients [57, 58].”
The Caenorhabditis elegans K10C2.4 Gene Encodes a Member of the Fumarylacetoacetate Hydrolase Family
Fisher, A. L., Page, K. E., Lithgow, G. J., & Nash, L. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m708341200 · Cited by 35
Nishikori, S., Yamanaka, K., Sakurai, T., Esaki, M., & Ogura, T. (2008) · Genes to Cells · doi:10.1111/j.1365-2443.2008.01214.x · Cited by 35
“Plasmid expressing GST-ataxin2-Q56 was constructed by inserting the truncated ataxin2-Q56 sequence from pT-SCA2-Q56-GFP (a generous gift from Dr O. Onodera) (Nozaki et al. 2001) into pGEX-6p-3.”
Consequences of inner mitochondrial membrane protein misfolding
Coyne, L. P., & Chen, X. J. (2019) · Mitochondrion · doi:10.1016/j.mito.2019.06.001 · Cited by 37
Harrington, A. J., Knight, A. L., Caldwell, G. A., & Caldwell, K. A. (2011) · Methods · doi:10.1016/j.ymeth.2010.12.036 · Cited by 35
Proteostasis in neurodegenerative diseases
Kinger, S., Jagtap, Y. A., Kumar, P., Choudhary, A., Prasad, A., Prajapati, V. K., Kumar, A., Mehta, G., & Mishra, A. (2024) · Advances in clinical chemistry · doi:10.1016/bs.acc.2024.04.002 · Cited by 36
The TRiCky Business of Protein Folding in Health and Disease
Ghozlan, H. H., Cox, A., Nierenberg, D., King, S. J., & Khaled, A. R. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.906530 · Cited by 34
“In a genome wide screen for genes that could regulate polyQ aggregation, a number of genes involved in protein folding were identified, including HSP70, CCT5, and five other CCT subunits (Nollen et al., 2004).”
Identification of Human Proteins That Modify Misfolding and Proteotoxicity of Pathogenic Ataxin-1
Petrakis, S., Raskó, T., Russ, J., Friedrich, R. P., Strödicke, M., Riechers, S., Muehlenberg, K., Möller, A., Reinhardt, A., Vinayagam, A., et al. (2012) · PLoS Genetics · doi:10.1371/journal.pgen.1002897 · Cited by 38
“Of these, 19 are human homologues of known modifiers of polyQ toxicity or aggregation in lower model organisms [19,20,24].”
Proteomics: a strategy to understand the novel targets in protein misfolding and cancer therapy
Nagathihalli, N. S., Singh, O. V., & Merchant, N. B. (2010) · Expert Review of Proteomics · doi:10.1586/epr.10.70 · Cited by 35
Chen, X., & Burgoyne, R. D. (2012) · BMC Genomics · doi:10.1186/1471-2164-13-71 · Cited by 37
“elegans models of both polyQ and a-synuclein aggregation reported only a single gene overlap from a large number of hits identified [9,10].”
InfluentialMechanism and regulation of translation in C. elegans
Rhoads, R. E., Dinkova, T. D., & Korneeva, N. L. (2006) · WormBook · doi:10.1895/wormbook.1.63.1 · Cited by 38
“The two eEF2 homologs, EFT-1 (Ofulue and Candido, 1992) and EFT-2 (Ofulue and Candido, 1991; Nollen et al., 2004), are expressed during all stages and are encoded by essential genes. eRF1 has two splice variants whereas eRF3 has only one.”
Genome‐wide application of RNAi to the discovery of potential drug targets
Ito, M., Kawano, K., Miyagishi, M., & Taira, K. (2005) · FEBS Letters · doi:10.1016/j.febslet.2005.08.015 · Cited by 35
Silva, M. C., Amaral, M. D., & Morimoto, R. I. (2013) · PLoS Genetics · doi:10.1371/journal.pgen.1003711 · Cited by 36
“The strains utilized in this work were previously described: wildtype (wt) Bristol strain N2; polyQ strains Q24 AM138 (rmIs130[Punc-54::q24::yfp]II), Q35 AM140 (rmIs132[Punc-54::q35::yfp]I), Q37 AM470 (rmIs225[Punc-54::q37::yfp]II) [16,17]; human SOD1 G93A AM265 (rmIs177[Punc-54::sod1 ::yfp]) [5]; intestinal Q44 GF80…”
Self-citationGutiérrez-García, R., Koyuncu, S., Hommen, F., Bilican, S., Lee, H. J., Fatima, A., & Vílchez, D. (2022) · Human Molecular Genetics · doi:10.1093/hmg/ddac304 · Cited by 36
Beam, M., Silva, M. C., & Morimoto, R. I. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.362764 · Cited by 34
“The polyglutamine strains, expressing different lengths of CAG-repeats fused with YFP, have been described elsewhere: Q0 AM134 (rmIs126[Punc-54::Q0::yfp]X); Q24 AM138 (rmIs130[Punc-54::q24::yfp]II); Q35 AM140 (rmIs132[Punc-54::q35::yfp]I); Q37 AM470 (rmIs225[Punc-54::q37::yfp]II); and Q40 AM141 (rmIs133[Punc-54::Q40::…”
Self-citationBross, P., Li, Z., Hansen, J., Hansen, J. J., Nielsen, M. N., Corydon, T. J., Georgopoulos, C. P., Ang, D., Banner, J., Niezen‐Koning, K. E., et al. (2006) · Journal of Human Genetics · doi:10.1007/s10038-006-0080-7 · Cited by 34
“Genetic screens of neurodegenerative disease models have indeed shown that molecular chaperones, intracellular proteases and other components involved in protein quality control represent a prominent group of such modifier genes (Fernandez-Funez et al. 2000; Bonini and Fortini 2003; Nollen et al. 2004).”
Gidalevitz, T., Wang, N., Deravaj, T., Alexander-Floyd, J., & Morimoto, R. I. (2013) · BMC Biology · doi:10.1186/1741-7007-11-100 · Cited by 38
“elegans shows a striking age-dependent onset of aggregation, regulated by heat shock factor 1 (HSF1) and the insulin signaling pathway [25,26,67].”
Self-citationOxidative Stress and Neurodegeneration: Interconnected Processes in PolyQ Diseases
Gkekas, I., Gioran, A., Boziki, M. K., Grigoriadis, N., Chondrogianni, N., & Petrakis, S. (2021) · Antioxidants · doi:10.3390/antiox10091450 · Cited by 33
Interplay between protein homeostasis networks in protein aggregation and proteotoxicity
Douglas, P. M., & Cyr, D. (2009) · Biopolymers · doi:10.1002/bip.21304 · Cited by 34
Haldimann, P., Muriset, M., Vígh, L., & Goloubinoff, P. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.234773 · Cited by 32
Caenorhabditis elegans Models to Investigate the Mechanisms Underlying Tau Toxicity in Tauopathies
Natale, C., Barzago, M. M., & Diomede, L. (2020) · Brain Sciences · doi:10.3390/brainsci10110838 · Cited by 31
Perni, M., van der Goot, A., Limbocker, R., van Ham, T. J., Aprile, F. A., Xu, C. K., Flagmeier, P., Thijssen, K. L., Sormanni, P., Fusco, G., et al. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.552549 · Cited by 32
“As direct observations of the nature and kinetics of the aggregation processes taking place in vivo provide opportunities to extend such findings to physiological conditions (Morley et al., 2002; Nollen et al., 2004; Van Ham et al., 2008; Van der Goot et al., 2012; Habchi et al., 2016), we investigated here the develo…”
Self-citationFrom sequence to function: using RNAi to elucidate mechanisms of human disease
Wolters, N. M., & MacKeigan, J. P. (2008) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4402311 · Cited by 30
C. elegans as an Animal Model to Study the Intersection of DNA Repair, Aging and Neurodegeneration
Naranjo-Galindo, F. J., Ai, R., Fang, E. F., Nilsen, H. L., & SenGupta, T. (2022) · Frontiers in Aging · doi:10.3389/fragi.2022.916118 · Cited by 31
“These studies provided the tools necessary for carrying out screenings for modifiers of polyQ aggregation (Nollen et al., 2004; Voisine et al., 2007) and show how the presence of misfolded proteins affect the cellular environment (Holmberg et al., 2004; Gidalevitz et al., 2006).”
Identification of genes in toxicity pathways of trinucleotide-repeat RNA in C. elegans
Garcia, S. M. D. A., Tabach, Y., Lourenco, G. F., Armakola, M., & Ruvkun, G. (2014) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.2858 · Cited by 29
“…CUG toxicity are modulators of polyQ aggregation or toxicity, hda-2, mrt-2 and smg-2 genes 21,23 . npp-4 , although not previously linked to repeat expansion disorders, is part of the nuclear pore complex together with npp-8 , and npp-8 had been identified as a modulator of polyQ aggregation 30 .”
Self-citationThe contribution of C. elegans neurogenetics to understanding neurodegenerative diseases
Liang, J., McKinnon, I. A., & Rankin, C. H. (2020) · Journal of Neurogenetics · doi:10.1080/01677063.2020.1803302 · Cited by 30
Metadata
- Authors
- Nollen, E. A. A., Garcia, S. M., van Haaften, G., Kim, S., Chavez, A., Morimoto, R. I., & Plasterk, R. H. A.
- Affiliations
- Northwestern University (US)
- Division of Functional Genomics, Hubrecht Laboratories/Netherlands Institute for Developmental Biology, 3584 CT Utrecht, The Netherlands; and Department of Biochemistry, Molecular Biology, and Cell Biology, Rice Institute for Biomedical Research, Northwestern University, Evanston, IL 60208
- ORCID
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2004-04-14
- Volume
- 101
- Issue
- 17
- Pages
- 6403-6408
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC404057
- OpenAlex
- W1511237419
- Cited by
- 416
- References
- 35
- Citations by year
- 2026: 4 · 2025: 9 · 2024: 20 · 2023: 7 · 2022: 18 · 2021: 18 · 2020: 15 · 2019: 9 · 2018: 11 · 2017: 15 · 2016: 16 · 2015: 14 · 2014: 22 · 2013: 20 · 2012: 26
- FWCI
- 10.21
- Type
- journal article
- Language
- en
- Open access
- green
- europepmc.org
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Genetic Neurodegenerative Diseases
- Health Sciences › Medicine › Clinical Neurology › Amyotrophic Lateral Sclerosis Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Heat shock proteins research
- Keywords
- polyglutamine aggregation, protein misfolding, proteostasis, polyglutamine diseases, RNAi screen, Caenorhabditis elegans, RNA metabolism, protein synthesis, protein folding, protein degradation, protein trafficking, neurodegenerative diseases
- MeSH terms
- Animals, Microscopy, Electron, Peptides, Blotting, Western, Genome, Caenorhabditis elegans, RNA Interference
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.